$SNYR
Synergy CHC Corp.

2024 Q4 Form 10-Q Financial Statement

#000121390024106476 Filed on December 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2024 Q2
Revenue $7.126M
YoY Change -34.05%
Cost Of Revenue $2.336M
YoY Change -22.86%
Gross Profit $4.790M
YoY Change -38.41%
Gross Profit Margin 67.22%
Selling, General & Admin $3.706M
YoY Change -34.16%
% of Gross Profit 77.37%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.740M
YoY Change -33.57%
Operating Profit $1.051M
YoY Change -51.1%
Interest Expense $378.2K
YoY Change -15.32%
% of Operating Profit 35.99%
Other Income/Expense, Net $459.6K
YoY Change -47.66%
Pretax Income $591.3K
YoY Change -53.47%
Income Tax -$192.3K
% Of Pretax Income -32.52%
Net Earnings $783.6K $655.2K
YoY Change -38.98% -69.31%
Net Earnings / Revenue 11.0%
Basic Earnings Per Share $0.10
Diluted Earnings Per Share $0.10
COMMON SHARES
Basic Shares Outstanding 8.704M shares 7.554M shares
Diluted Shares Outstanding 7.554M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $259.4K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.911M
Prepaid Expenses $1.073M
Receivables $4.072M
Other Receivables
Total Short-Term Assets $11.85M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $316.7K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $316.7K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $11.85M
Total Long-Term Assets $316.7K
Total Assets $12.17M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue $2.100K
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due $6.995M
YoY Change
Total Short-Term Liabilities $18.25M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $19.09M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $18.25M
Total Long-Term Liabilities $19.09M
Total Liabilities $37.34M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$44.33M
YoY Change
Common Stock $19.16M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$25.17M -$25.88M
YoY Change
Total Liabilities & Shareholders Equity $12.17M
YoY Change

Cashflow Statement

Concept 2024 Q4 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $783.6K $655.2K
YoY Change -38.98% -69.31%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-42374
dei Entity Registrant Name
EntityRegistrantName
SYNERGY CHC CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0379440
dei Entity Address Address Line1
EntityAddressAddressLine1
865 Spring Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Westbrook
dei Entity Address State Or Province
EntityAddressStateOrProvince
ME
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
04092
dei City Area Code
CityAreaCode
(207)
dei Local Phone Number
LocalPhoneNumber
321-2350
dei Security12b Title
Security12bTitle
Common stock, par value $0.00001 per share
dei Trading Symbol
TradingSymbol
SNYR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8703818 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
259375 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
632534 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4072030 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2106094 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1072639 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
797985 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1910515 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3726240 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
11853286 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
11822849 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316667 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416667 usd
CY2024Q3 us-gaap Assets
Assets
12169953 usd
CY2023Q4 us-gaap Assets
Assets
12239516 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5082140 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11727490 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
254272 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
185665 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2100 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14202 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6994766 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2094525 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
18248970 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5381 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
68607 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12102 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3434 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3011384 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9335734 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
102206 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-100242 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1377479 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2737849 usd
snyr Advances From Related Party
AdvancesFromRelatedParty
3395587 usd
snyr Advances From Related Party
AdvancesFromRelatedParty
1000000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
157425 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-84500 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-73500 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
600000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
360000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2857690 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
733010 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
895972 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14021882 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
9757022 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
13096610 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
19090075 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
25523607 usd
CY2024Q3 us-gaap Liabilities
Liabilities
37339045 usd
CY2023Q4 us-gaap Liabilities
Liabilities
39545489 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
76 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
76 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19157931 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19148707 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5881 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-102467 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44332980 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-46352289 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-25169092 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-27305973 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12169953 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12239516 usd
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
29559440 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2335901 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3028023 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7421930 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8351645 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
4790432 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
7777712 usd
us-gaap Gross Profit
GrossProfit
17141106 usd
us-gaap Gross Profit
GrossProfit
21207795 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2509440 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4302034 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9149303 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10533217 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1196784 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1326864 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3449007 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4294634 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33333 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3739557 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5628898 usd
us-gaap Operating Expenses
OperatingExpenses
12698310 usd
us-gaap Operating Expenses
OperatingExpenses
14827851 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1050875 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
2148814 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4442796 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
6379944 usd
CY2024Q3 us-gaap Other Income
OtherIncome
-252405 usd
us-gaap Other Income
OtherIncome
-252405 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-704707 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-885548 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-2559454 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
-2605320 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
7279 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-7555 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2166 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11716 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
459581 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
877993 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2309215 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2593604 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
591294 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1270821 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2133581 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3786340 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192299 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13366 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114272 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38896 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
783593 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1284187 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Net Income Loss
NetIncomeLoss
3747444 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
783593 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1284187 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Net Income Loss
NetIncomeLoss
3747444 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
79025 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-105398 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-108348 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
4257 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
704568 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1389585 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2127657 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3743187 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-33519867 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-4443 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
328428 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-33195882 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-105212 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2134829 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-31166264 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
105398 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1284187 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-29776680 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-27305973 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
131637 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
580530 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-26593806 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4611 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
55736 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
655186 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-25878273 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4613 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-79025 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
783593 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-25169092 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Net Income Loss
NetIncomeLoss
3747444 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
47519 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
37838 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9224 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
23777 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
16146 usd
snyr Foreign Currency Transactions Gain Before Tax
ForeignCurrencyTransactionsGainBeforeTax
-2166 usd
snyr Foreign Currency Transactions Gain Before Tax
ForeignCurrencyTransactionsGainBeforeTax
11716 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
4799 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
21994 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1965936 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-102649 usd
us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
-21269 usd
us-gaap Increase Decrease In Notes Receivable Related Parties Current
IncreaseDecreaseInNotesReceivableRelatedPartiesCurrent
-118192 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1815725 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-3829729 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
205975 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1029858 usd
snyr Increase Decrease In Prepaid Expense Related Party
IncreaseDecreaseInPrepaidExpenseRelatedParty
396683 usd
snyr Increase Decrease In Prepaid Expense Related Party
IncreaseDecreaseInPrepaidExpenseRelatedParty
143106 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-5381 usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
68607 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-12102 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
3434 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3011384 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9335734 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
102206 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-100242 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2737849 usd
snyr Advances From Related Party
AdvancesFromRelatedParty
3395587 usd
snyr Advances From Related Party
AdvancesFromRelatedParty
1000000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
157425 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-84500 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
600000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
360000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2857690 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
733010 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
895972 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108348 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4257 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-373159 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2188616 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
732534 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2526443 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
359375 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
337827 usd
us-gaap Interest Paid
InterestPaid
2432653 usd
us-gaap Interest Paid
InterestPaid
2584604 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
45664 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3770824 usd
us-gaap Stock Issued1
StockIssued1
328003 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – Nature of the Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisitions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2019 the Company has merged its U.S. subsidiaries (Neuragen Corp., Breakthrough Products, Inc., Sneaky Vaunt Corp., and The Queen Pegasus Corp.) into the parent company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy is the sole owner of two subsidiaries: NomadChoice Pty Ltd., and Synergy CHC Inc. and the results have been consolidated in these statements.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates included are assumptions about collection of accounts receivable, current income taxes, deferred income taxes valuation allowance, useful life of intangible assets, impairment analysis of intangible assets, estimates used in the fair value calculation of stock based compensation, assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate and expected dividend rate, accrual of sales returns, and accrual of legal expense. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
553490 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
108348 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4257 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2188616 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
732534 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2526443 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
359375 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
337827 usd
us-gaap Interest Paid
InterestPaid
2432653 usd
us-gaap Interest Paid
InterestPaid
2584604 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
45664 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3770824 usd
us-gaap Stock Issued1
StockIssued1
328003 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – Nature of the Business</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy CHC Corp. (“Synergy”, “we”, “us”, “our” or the “Company”) (formerly Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name “Oro Capital Corporation.” On April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its name to “Synergy Strips Corp.”. On August 5, 2015, the Company changed its name to “Synergy CHC Corp.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Synergy’s strategy is to grow its portfolio both organically and by further acquisitions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective January 1, 2019 the Company has merged its U.S. subsidiaries (Neuragen Corp., Breakthrough Products, Inc., Sneaky Vaunt Corp., and The Queen Pegasus Corp.) into the parent company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy is the sole owner of two subsidiaries: NomadChoice Pty Ltd., and Synergy CHC Inc. and the results have been consolidated in these statements.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Use of Estimates</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates included are assumptions about collection of accounts receivable, current income taxes, deferred income taxes valuation allowance, useful life of intangible assets, impairment analysis of intangible assets, estimates used in the fair value calculation of stock based compensation, assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate and expected dividend rate, accrual of sales returns, and accrual of legal expense. The results of any changes in accounting estimates are reflected in the financial statements in the period in which the changes become evident. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the period that they are determined to be necessary.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2024Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
98254 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
441711 usd
CY2024Q3 us-gaap Cash
Cash
259375 usd
CY2023Q4 us-gaap Cash
Cash
632534 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
359375 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
732534 usd
CY2024Q3 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
98254 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
441711 usd
CY2024Q3 us-gaap Cash
Cash
259375 usd
CY2023Q4 us-gaap Cash
Cash
632534 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
100000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
359375 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
732534 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5197 usd
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
2100 usd
CY2023 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
14202 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-5197 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14202 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149446 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14202 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5197 usd
us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
2100 usd
CY2023 us-gaap Contract With Customer Liability Increase Decrease For Contract Acquired In Business Combination
ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination
14202 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-14202 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-5197 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2100 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14202 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149446 usd
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1284187 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Net Income Loss
NetIncomeLoss
3747444 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
783593 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1284187 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Net Income Loss
NetIncomeLoss
3747444 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7553818 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7553818 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.5
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.5
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Concentrations of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management’s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.</span></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Concentrations of Credit Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company provides credit terms to its customers; however, collateral is not required. Accordingly, the Company performs credit evaluations of its customers and maintains allowances for possible losses which, when realized, were within the range of management’s expectations. From time to time, a higher concentration of credit risk exists on outstanding accounts receivable for a select number of customers due to individual buying patterns.</span></p>
us-gaap Other Income
OtherIncome
-252405 usd
CY2024Q3 us-gaap Other Income
OtherIncome
-252405 usd
us-gaap Other Income
OtherIncome
-252405 usd
CY2024Q3 us-gaap Other Income
OtherIncome
-252405 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44332980 usd
CY2024Q3 snyr Working Capital Deficit
WorkingCapitalDeficit
6395684 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1377479 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114272 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38896 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13366 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
51800000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44332980 usd
CY2024Q3 snyr Working Capital Deficit
WorkingCapitalDeficit
6395684 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1377479 usd
us-gaap Net Income Loss
NetIncomeLoss
2019309 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38896 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-192299 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13366 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
51800000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
52800000 usd
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
52800000 usd
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2024Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4072030 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2255540 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149446 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4072030 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2106094 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
230128 usd
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
128025 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
6220 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
6133 usd
CY2024Q3 us-gaap Deposit Assets
DepositAssets
14000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
60000 usd
CY2024Q3 snyr Contract Employee Related Party
ContractEmployeeRelatedParty
570000 usd
CY2023Q4 snyr Contract Employee Related Party
ContractEmployeeRelatedParty
501321 usd
CY2023Q4 snyr Components
Components
97606 usd
CY2024Q3 snyr Promotions
Promotions
144448 usd
CY2024Q3 snyr It Expenses
ITExpenses
14951 usd
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
92372 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
520 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4900 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1072639 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
797985 usd
CY2024Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4072030 usd
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
2255540 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
149446 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4072030 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2106094 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 usd
CY2024Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
230128 usd
CY2023Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
128025 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
6220 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
6133 usd
CY2024Q3 us-gaap Deposit Assets
DepositAssets
14000 usd
CY2023Q4 us-gaap Deposit Assets
DepositAssets
60000 usd
CY2024Q3 snyr Contract Employee Related Party
ContractEmployeeRelatedParty
570000 usd
CY2023Q4 snyr Contract Employee Related Party
ContractEmployeeRelatedParty
501321 usd
CY2023Q4 snyr Components
Components
97606 usd
CY2024Q3 snyr Promotions
Promotions
144448 usd
CY2024Q3 snyr It Expenses
ITExpenses
14951 usd
CY2024Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
92372 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
520 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4900 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1072639 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
797985 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
98254 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
441711 usd
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
98254 usd
CY2023Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
441711 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1771566 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3584343 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
93949 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
93949 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2948 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
45000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
45000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1910515 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3726240 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2948 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133333 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33333 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1771566 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3584343 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
93949 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
93949 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2948 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
45000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
45000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1910515 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
3726240 usd
CY2023Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
2948 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
450000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133333 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
33333 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316667 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416667 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33333 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316667 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416667 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
33333 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
33333 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
133333 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
133333 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16668 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
388360 usd
snyr Prepaid Consulting Fees
PrepaidConsultingFees
396683 usd
CY2024Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
328003 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
375587 usd
us-gaap Interest Expense
InterestExpense
1488475 usd
us-gaap Interest Expense
InterestExpense
1279646 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
378214 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
446619 usd
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
123331 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
33333 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16668 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
0 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
0 usd
us-gaap Professional Fees
ProfessionalFees
388360 usd
snyr Prepaid Consulting Fees
PrepaidConsultingFees
396683 usd
CY2024Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
328003 usd
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
375587 usd
us-gaap Interest Expense
InterestExpense
1488475 usd
us-gaap Interest Expense
InterestExpense
1279646 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
378214 usd
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
123331 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
104054 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
329652 usd
CY2024Q3 snyr Accrued Legal Fees Current
AccruedLegalFeesCurrent
107373 usd
CY2023Q4 snyr Accrued Legal Fees Current
AccruedLegalFeesCurrent
707590 usd
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1187864 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
601988 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
104054 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
329652 usd
CY2024Q3 snyr Accrued Legal Fees Current
AccruedLegalFeesCurrent
107373 usd
CY2023Q4 snyr Accrued Legal Fees Current
AccruedLegalFeesCurrent
707590 usd
CY2024Q3 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
1187864 usd
CY2023Q4 us-gaap Accrued Sales Commission Current
AccruedSalesCommissionCurrent
601988 usd
CY2024Q3 snyr Accrued Manufacturers Cost Current
AccruedManufacturersCostCurrent
1009481 usd
CY2023Q4 snyr Accrued Manufacturers Cost Current
AccruedManufacturersCostCurrent
4424146 usd
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
223138 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3315755 usd
CY2024Q3 snyr Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
260967 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5760 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
19324 usd
CY2024Q3 snyr Accrued Warehousing Current
AccruedWarehousingCurrent
787745 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
18364 usd
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
853685 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
871047 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
45363 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
41556 usd
CY2024Q3 snyr Accrued Inventory Current
AccruedInventoryCurrent
4596 usd
CY2023Q4 snyr Accrued Inventory Current
AccruedInventoryCurrent
49972 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
92942 usd
CY2024Q3 snyr Interest Related Party Current
InterestRelatedPartyCurrent
123331 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7561 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
224681 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
154989 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5082140 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11727490 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2888 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
6098 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6994766 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2094525 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
9757022 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13096610 usd
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12500 usd
CY2024Q3 snyr Accrued Manufacturers Cost Current
AccruedManufacturersCostCurrent
1009481 usd
CY2023Q4 snyr Accrued Manufacturers Cost Current
AccruedManufacturersCostCurrent
4424146 usd
CY2024Q3 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
223138 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
3315755 usd
CY2024Q3 snyr Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
260967 usd
CY2023Q4 snyr Accrued Accounting Fees Current
AccruedAccountingFeesCurrent
223286 usd
CY2024Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5760 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
19324 usd
CY2024Q3 snyr Accrued Warehousing Current
AccruedWarehousingCurrent
787745 usd
CY2023Q4 snyr Accrued Warehousing Current
AccruedWarehousingCurrent
962260 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
51160 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
18364 usd
CY2024Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
853685 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
871047 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
45363 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
41556 usd
CY2024Q3 snyr Accrued Inventory Current
AccruedInventoryCurrent
4596 usd
CY2023Q4 snyr Accrued Inventory Current
AccruedInventoryCurrent
49972 usd
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
92942 usd
CY2024Q3 snyr Interest Related Party Current
InterestRelatedPartyCurrent
123331 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7561 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
224681 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
154989 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5082140 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
11727490 usd
CY2024Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2888 usd
CY2023Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
6098 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
6994766 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2094525 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
9757022 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
13096610 usd
CY2015Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
12500 usd
CY2015Q3 snyr Net Sales Percentage
NetSalesPercentage
0.05 pure
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1200000 usd
CY2024Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
199640 usd
CY2023Q4 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
204941 usd
CY2024Q1 snyr Owned Subsidiary Assets
OwnedSubsidiaryAssets
275000 usd
CY2023Q4 snyr Owned Subsidiary Assets
OwnedSubsidiaryAssets
287500 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
7199 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
7520 usd
CY2017Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
20000000 usd
CY2017Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
100000 usd
CY2024Q3 snyr Work Fee Percentage
WorkFeePercentage
0.01 pure
CY2020Q2 us-gaap Legal Fees
LegalFees
25000 usd
CY2015Q3 snyr Net Sales Percentage
NetSalesPercentage
0.05 pure
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1200000 usd
CY2024Q1 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
199640 usd
CY2024Q1 snyr Owned Subsidiary Assets
OwnedSubsidiaryAssets
275000 usd
CY2023Q4 snyr Owned Subsidiary Assets
OwnedSubsidiaryAssets
287500 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
7199 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
7520 usd
CY2017Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
20000000 usd
CY2017Q3 us-gaap Loan Portfolio Expense
LoanPortfolioExpense
100000 usd
CY2024Q3 snyr Work Fee Percentage
WorkFeePercentage
0.01 pure
CY2020Q2 us-gaap Legal Fees
LegalFees
25000 usd
CY2020Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2021-05-08
CY2020Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.125 pure
CY2020Q2 snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
3000000 usd
snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
4000000 usd
CY2023Q2 snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
1000000 usd
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
30000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1448475 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1279646 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
378214 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
446619 usd
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
123331 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2026Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
450000 usd
CY2024Q3 us-gaap Other Notes Payable
OtherNotesPayable
83250 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000 usd
us-gaap Royalty Expense
RoyaltyExpense
536730 usd
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.05 pure
us-gaap Legal Fees
LegalFees
1000000 usd
CY2024Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1800000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
50000000 usd
CY2024Q3 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
500000 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
30000000 usd
snyr Jack Ross Shall Sell Amount
JackRossShallSellAmount
1 usd
snyr Kti Shares
KTIShares
5400000 shares
CY2024Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12333052 usd
CY2023 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12426997 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
500000 usd
CY2022Q1 us-gaap Loans Payable
LoansPayable
2000000 usd
CY2022Q1 us-gaap Loans Payable
LoansPayable
6000000 usd
CY2022Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
6000000 usd
CY2022Q1 snyr Stock Covering Principal Repayment Percent
StockCoveringPrincipalRepaymentPercent
0.10 pure
CY2022Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
6000000 usd
CY2022Q1 snyr Warrant Percentage
WarrantPercentage
0.10 pure
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6000000 usd
CY2023Q3 snyr Pro Rata Closing Fee
ProRataClosingFee
125000 usd
CY2024Q1 snyr Renegotiation Fee
RenegotiationFee
500000 usd
CY2024Q1 snyr Bonus Fee Payable
BonusFeePayable
1800000 usd
CY2024Q1 us-gaap Incentive Fee Payable
IncentiveFeePayable
563092 usd
CY2020Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2021-05-08
CY2020Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.125 pure
CY2020Q2 snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
3000000 usd
snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
4000000 usd
CY2023Q2 snyr Earnings Before Interest Tax Depreciation And Amortization
EarningsBeforeInterestTaxDepreciationAndAmortization
1000000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
1448475 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
378214 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
446619 usd
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
123331 usd
CY2024Q1 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2023Q4 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
1760076 usd
CY2026Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
450000 usd
CY2024Q3 us-gaap Other Notes Payable
OtherNotesPayable
83250 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
1000000 usd
us-gaap Royalty Expense
RoyaltyExpense
536730 usd
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.05 pure
us-gaap Legal Fees
LegalFees
1000000 usd
CY2024Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
1800000 usd
us-gaap Pre Opening Costs
PreOpeningCosts
50000000 usd
CY2024Q3 us-gaap Compensation And Benefits Trust
CompensationAndBenefitsTrust
500000 usd
us-gaap Revenues Net Of Interest Expense
RevenuesNetOfInterestExpense
30000000 usd
snyr Jack Ross Shall Sell Amount
JackRossShallSellAmount
1 usd
snyr Kti Shares
KTIShares
5400000 shares
CY2024Q2 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12333052 usd
CY2023 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
12426997 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
500000 usd
CY2022Q1 us-gaap Loans Payable
LoansPayable
2000000 usd
CY2022Q1 us-gaap Loans Payable
LoansPayable
6000000 usd
CY2022Q1 us-gaap Notes And Loans Payable
NotesAndLoansPayable
6000000 usd
CY2022Q1 snyr Stock Covering Principal Repayment Percent
StockCoveringPrincipalRepaymentPercent
0.10 pure
CY2022Q1 snyr Warrant Percentage
WarrantPercentage
0.10 pure
CY2022Q1 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
6000000 usd
CY2023Q3 snyr Pro Rata Closing Fee
ProRataClosingFee
125000 usd
CY2024Q1 snyr Renegotiation Fee
RenegotiationFee
500000 usd
CY2024Q1 snyr Bonus Fee Payable
BonusFeePayable
1800000 usd
CY2024Q1 us-gaap Incentive Fee Payable
IncentiveFeePayable
563092 usd
CY2022Q1 us-gaap Loans Payable
LoansPayable
6000000 usd
CY2022Q3 snyr Warrant Discount Rate
WarrantDiscountRate
0.25 pure
snyr Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
1000000 usd
snyr Earnings Before Interest Taxes Depreciation And Amortization Net Sales
EarningsBeforeInterestTaxesDepreciationAndAmortizationNetSales
30000000 usd
CY2024Q1 snyr Loan Renegotiation Fee
LoanRenegotiationFee
500000 usd
CY2024Q1 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
6900000 usd
CY2023 snyr Warrant Conversion To Loan
WarrantConversionToLoan
1500000 usd
CY2022Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
2000000 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
418100 usd
CY2022Q3 snyr Warrant Discount Rate
WarrantDiscountRate
0.25 pure
snyr Earnings Before Interest Taxes Depreciation And Amortization
EarningsBeforeInterestTaxesDepreciationAndAmortization
1000000 usd
snyr Earnings Before Interest Taxes Depreciation And Amortization Net Sales
EarningsBeforeInterestTaxesDepreciationAndAmortizationNetSales
30000000 usd
CY2024Q1 snyr Loan Renegotiation Fee
LoanRenegotiationFee
500000 usd
CY2024Q1 us-gaap Principal Amount Outstanding On Loans Securitized
PrincipalAmountOutstandingOnLoansSecuritized
6900000 usd
CY2023 snyr Warrant Conversion To Loan
WarrantConversionToLoan
1500000 usd
CY2022Q1 us-gaap Proceeds From Loans
ProceedsFromLoans
2000000 usd
CY2024Q2 us-gaap Loans Payable
LoansPayable
418100 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2023Q4 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
2235986 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
5450000 usd
CY2023Q3 snyr Asserted Claims
AssertedClaims
1000000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7553818 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7553818 shares
CY2023Q4 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
2235986 usd
CY2023Q4 us-gaap Other Loans Payable
OtherLoansPayable
5450000 usd
CY2023Q3 snyr Asserted Claims
AssertedClaims
1000000 usd
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.98
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
10.71
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
336136 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y4M2D
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
7.29
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
252102 shares
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.15
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
2.98
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
10.71
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
336136 shares
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y4M2D
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
7.29
CY2024Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
252102 shares
CY2024Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
6.15
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
252102 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
84034 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.71
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336136 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.29
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4613 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9224 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0433 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
46118 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P30M
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
252102 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
84034 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.71
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
336136 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.29
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4613 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9224 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0433 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
46118 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P30M
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
29559440 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
29559440 usd
us-gaap Revenues
Revenues
24563036 usd
CY2024Q3 us-gaap Revenues
Revenues
7126333 usd
CY2023Q3 us-gaap Revenues
Revenues
10805735 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
29559440 usd
us-gaap Revenues
Revenues
24563036 usd
us-gaap Revenues
Revenues
29559440 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316667 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416667 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2023Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
us-gaap Revenues
Revenues
29559440 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
316667 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
416667 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2023Q3 us-gaap Other Income
OtherIncome
usd
us-gaap Other Income
OtherIncome
usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
usd
CY2024Q3 snyr Components
Components
usd
CY2023Q4 snyr Promotions
Promotions
usd
CY2023Q4 snyr It Expenses
ITExpenses
usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2024Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
usd
CY2024Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
usd
CY2024Q3 snyr Components
Components
usd
CY2023Q4 snyr Promotions
Promotions
usd
CY2023Q4 snyr It Expenses
ITExpenses
usd
CY2023Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
usd
CY2024Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
usd
CY2024Q3 us-gaap Other Inventory In Transit
OtherInventoryInTransit
usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2023Q4 snyr Interest Related Party Current
InterestRelatedPartyCurrent
usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001562733
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
usd
CY2023Q4 snyr Interest Related Party Current
InterestRelatedPartyCurrent
usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001562733

Files In Submission

Name View Source Status
0001213900-24-106476-index-headers.html Edgar Link pending
0001213900-24-106476-index.html Edgar Link pending
0001213900-24-106476.txt Edgar Link pending
0001213900-24-106476-xbrl.zip Edgar Link pending
ea0223497-10q_synergy.htm Edgar Link pending
ea022349701ex31-1_synergy.htm Edgar Link pending
ea022349701ex31-2_synergy.htm Edgar Link pending
ea022349701ex32-1_synergy.htm Edgar Link pending
ea022349701ex32-2_synergy.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snyr-20240930.xsd Edgar Link pending
snyr-20240930_cal.xml Edgar Link unprocessable
snyr-20240930_def.xml Edgar Link unprocessable
snyr-20240930_lab.xml Edgar Link unprocessable
snyr-20240930_pre.xml Edgar Link unprocessable
ea0223497-10q_synergy_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable